CSLM KOYNU Stalls at 1025 Breakout or Breakdown 20260515 Nigel Farage Faces Parliamentary Inquiry Over 5m Crypto Billionaire Gift Starry Sea SSEAR Stalls at 018 Consolidation Phase 20260515 Bangkok Freight Train Crash Driver Drug Test Positive Raises Safety Oversight Concerns Mortgage Rate Shopping How Comparing Lenders Could Save Thousands Prediction Markets Surge Among Young Male Demographics Industry Reaches MultiBillion Dollar Scale SP 500 MeltUp Scenario Could the Index Reach 8000 Amazon UK Boss Criticises Education System Says Youth Unemployment Not Their Fault Indian Billionaires Accelerate Overseas Acquisitions as Domestic Growth Moderates CapitaLand Unveils S14 Billion Life Sciences Hub Geneo to Drive Innovation AIT Q1 2026 Earnings Narrow Profit Miss Amidst Steady Operational Performance Mistras Group Inc MG Q1 2026 Earnings EPS Surges Past Estimates with 55 Surprise DIS Q1 2026 Earnings Earnings Beat Driven by Streaming Progress and Theme Parks MDLN Q1 2026 Earnings EPS Beats Estimates by 95 Stock Edges Higher SOBO Q1 2026 Earnings EPS Misses Estimates by 37 Shares Dip Slightly LBRDA Q3 2025 Earnings EPS Surges Past Estimates Despite Broadband Headwinds SentinelOne S Gains 331 as Cybersecurity Stock Approaches Resistance at 1965 Oxford Lane Capital Notes Steady Near Support as Yield Attracts Simulations Plus Inc SLP Rises 172 Testing Key Resistance Zone Birkenstock BIRK Surges 416 as Shares Approach Key Resistance Level Match Group MTCH Edges Lower as Shares Test Key Support Levels BancFirst Corporation Q1 2026 Earnings EPS Beats Estimates Shares Edge Higher WST Q1 2026 Earnings EPS Surges Past Estimates Stock Moves Marginally Higher ALSN Q1 2026 Earnings Strong Earnings Beat Drives Positive Stock Response LAZ Q1 2026 Earnings Missed EPS Estimates Revenue Not Disclosed Shares Edge Higher EXPE Q1 2026 Earnings Strong EPS Beat Amidst Mixed Market Reaction India Government Plans Major Overhaul of Tax Administration to Facilitate Smooth GST Rollout CTOS Q1 2026 Earnings EPS Surprises with Smaller Loss but Stock Dips Biodexa Pharmaceuticals BDRX Extends Gains Testing Key Resistance at 344